NextNav Inc (NN) Stock News

Pomerantz LLP filed a class action lawsuit against Nano-X Imaging Ltd. and certain officers for alleged securities fraud. The lawsuit claims defendants made false statements about operational efficiency and demand, while the company was actually experiencing poor production alignment, increased expenses, and cash burn. The truth emerged on April 20, 2026, when Nano-X reported a $17.5 million impairment charge related to restructuring its Korean manufacturing facility and announced its CFO's departure, causing the stock to fall 24.39%.

INNIO N.V. (Nasdaq: INIO) announced a landmark 1.1 GW equipment order from a major data center developer, representing one of the largest orders in the company's history. The order includes over 200 Jenbacher J624 engines for behind-the-meter prime power generation across the United States, with phased deliveries providing multi-year revenue visibility. The order was booked in Q2 2026 and reflects strong demand for on-site power solutions in the AI-driven data center sector.

The Schall Law Firm is seeking investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements about product demand and operational efficiency while suffering from poor customer alignment and increased cash burn.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against Nano-X Imaging Ltd. (NNOX) for allegedly making false statements about operational efficiency and product demand. The lawsuit claims the company overstated gains while experiencing poor manufacturing alignment, increased operating expenses, and significant cash burn, requiring restructuring charges. The lead plaintiff deadline is August 11, 2026.

Pomerantz LLP has filed a class action lawsuit against Nano-X Imaging Ltd. and certain officers for alleged violations of federal securities laws. The lawsuit claims defendants made materially false statements about operational efficiency and demand, when in reality the company experienced poor production alignment, increased operating expenses, and significant cash burn. The truth emerged on April 20, 2026, when Nano-X announced a $17.5 million impairment charge related to restructuring its Korean manufacturing facility and a shift to outsourced production, causing the stock to fall 24.39%.

Rosen Law Firm is urging investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that would require disruptive restructuring measures. The lead plaintiff deadline is August 11, 2026.

Rosen Law Firm is reminding investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 of an important August 11, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that necessitated restructuring.

ARCpoint Inc. (TSXV: ARC), a healthcare technology company, announced it will miss its July 29, 2026 filing deadline for annual financial statements due to lack of available funds to pay auditors. The company has applied for a Management Cease Trade Order (MCTO) and expects to file by September 29, 2026. During the MCTO period, insiders will be restricted from trading shares, though public trading will continue.

INNIO Group announced it will release its second quarter 2026 financial results on July 28, 2026, before market open, followed by a management conference call at 8:00 a.m. ET. The webcast and earnings materials will be available on the company's investor relations website.

Nano-X Imaging Ltd. (NNOX) investors have until August 11, 2026, to file motions to become lead plaintiffs in a securities class action lawsuit. The action stems from a 24.39% single-day stock decline on April 20, 2026, following disclosure of a $17.5 million asset impairment and closure of the company's South Korean chip manufacturing facility. Lead plaintiffs will oversee litigation regarding alleged misrepresentations about manufacturing efficiency and product demand during the March 31, 2025 to April 17, 2026 period.

Madonna returned to New York City to celebrate her No.1 album Confessions II through CLUB CONFESSIONS, an immersive nightlife experience presented in partnership with MISTR, a telemedicine platform providing free HIV prevention and sexual healthcare services. The event, held at Knockdown Center, featured performances by Stuart Price, Honey Dijon, and other artists, drawing celebrities from music, fashion, and entertainment while raising awareness for LGBTQ+ health initiatives.

Rosen Law Firm is urging investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that would require disruptive restructuring measures.

A securities class action lawsuit has been filed against Nano-X Imaging (NNOX) alleging the company made false statements about operational efficiency and product demand while concealing poor manufacturing alignment, increased cash burn, and restructuring risks. The lawsuit covers investors who purchased securities between March 31, 2025 and April 17, 2026. The deadline to seek lead plaintiff status is August 11, 2026. The action was triggered after Nano-X reported a $33.4 million net loss in Q4 2025, including a $17.5 million impairment charge related to restructuring at its Korean facility, causing the stock to fall 24.39%.

Rosen Law Firm is reminding investors in Nano-X Imaging Ltd. (NNOX) who purchased securities between March 31, 2025 and April 17, 2026 of an important August 11, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that company defendants made false statements about operational efficiency improvements and product demand, while concealing that manufacturing operations did not match actual demand, leading to increased operating expenses and cash burn.

Aimei Health Technology Co., Ltd. announced the termination of its Business Combination Agreement with United Hydrogen Group Inc. on July 7, 2026, due to failure to close the transaction by the outside date specified in the agreement. The company expressed confidence in identifying future transaction opportunities.

Rosen Law Firm is soliciting investors in Nano-X Imaging Ltd. (NNOX) who purchased securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that necessitated restructuring measures.

Israel's Netanyahu tells CNN he and Trump align on big things over Iran  Reuters

NN, Inc. has achieved qualification and received initial purchase orders from a leading robotic-assisted surgery platform manufacturer after successfully passing a critical facility audit at its Kentwood, Michigan plant. The company's medical products business pipeline has increased by approximately $25 million to $75 million overall, representing a significant milestone in its targeted medical market growth strategy.

A securities class action lawsuit has been filed against Nano-X Imaging (NNOX) alleging the company made false statements about operational efficiency and product demand while concealing poor manufacturing alignment, increased cash burn, and restructuring risks. The lawsuit covers purchases between March 31, 2025 and April 17, 2026. Investors have until August 11, 2026 to seek lead plaintiff status. The action follows Nano-X's April 2026 announcement of a $33.4 million quarterly loss including a $17.5 million asset impairment charge, which triggered a 24.39% stock price decline.

The Schall Law Firm is seeking investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements about product demand and operational efficiency gains while suffering from poor customer alignment and increased cash burn.

Flexible Solutions International (FSI) announced it has traded its remaining 19.9% stake in FL LLC to recover exclusive rights to manufacture and sell four agricultural products across Latin America, Central America, the Caribbean, and South America. The move follows an acquirer's failure to meet payment obligations on a previous 30.1% equity sale. CEO Dan O'Brien expects significant revenue recovery in the second half of 2026.

Rosen Law Firm is encouraging investors who purchased securities of Nano-X Imaging Ltd. (NNOX) between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The firm alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and cash burn. The lead plaintiff deadline is August 11, 2026. The firm is also investigating potential securities claims for ADMA Biologics and DNOW Inc.

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Erasca Inc., Nano-X Imaging Ltd., Microsoft Corporation, and Black Rock Coffee Bar Inc. The lawsuits allege that defendants made false or misleading statements regarding their business operations, product performance, and financial prospects. Investors have until mid-August 2026 to file lead plaintiff motions.

Hop-on, Inc.'s subsidiary Digitalage has received Apple App Store approval for its iOS application, completing its infrastructure development across IP protection, creator monetization, and mobile distribution. The platform offers creators 85% of gross subscription revenue and 50% of net advertising revenue, with a soft launch targeting influencers and Genesis Creator Pilot participants.

FOXO Technologies Inc. (OTC: FOXO) announced that its 3,000-to-1 reverse stock split became effective on June 30, 2026. The company's stock will trade under temporary symbol 'FOXOD' on July 1, 2026, reverting to 'FOXO' around July 20, 2026. The reverse split aims to increase per-share stock price to meet OTCQB quotation requirements (minimum $0.01) and potentially attract institutional investors and improve liquidity.

Holzer & Holzer, LLC announced lead plaintiff deadlines for multiple shareholder class action lawsuits against companies including Nano-X Imaging, Peabody Energy, and First Solar. The lawsuits allege materially false statements and/or failure to disclose material facts regarding operational efficiency, mine ramp-up projections, and tariff policy management respectively. Investors who purchased shares during specified periods and suffered losses are encouraged to seek lead plaintiff status by the announced deadlines in August 2026.

Holzer & Holzer, LLC announced lead plaintiff deadlines for multiple shareholder class action lawsuits. Nano-X Imaging faces allegations regarding false statements about operational efficiency and cash burn (deadline August 11, 2026). Peabody Energy is accused of misrepresenting its Centurion mine ramp-up and growth prospects (deadline August 24, 2026). First Solar faces claims about misstatements regarding its capacity to manage U.S. tariff policy impacts (deadline August 24, 2026).

Rosen Law Firm is encouraging investors who purchased securities of Nano-X Imaging Ltd. (NNOX) between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The firm alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that would require disruptive restructuring measures. The lead plaintiff deadline is August 11, 2026.

Kirby McInerney LLP has filed a securities fraud class action lawsuit against Nano-X Imaging Ltd. on behalf of investors who purchased securities between March 31, 2025 and April 17, 2026. The lawsuit alleges that Nano-X overstated operational efficiency gains and product demand while concealing poor alignment between production and actual demand, leading to increased operating expenses and cash burn. On April 20, 2026, Nano-X disclosed a $17.5 million impairment charge related to restructuring its Korean manufacturing facility and announced its CFO's departure, causing the stock to decline 25% from $2.85 to $2.15 per share.

Rosen Law Firm is urging investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a securities class action lawsuit. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and cash burn that necessitated restructuring measures.